Novel T regulatory cells come of age: The curious incident of a mouse in Tennessee, delayed thymectomy and chimeric receptors!
作者信息
Scott David W, Levings Megan K
机构信息
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, United States.
Department of Surgery, University of British Columbia, Vancouver, BC V5Z 4H4, Canada.
出版信息
Cell Immunol. 2021 Jan;359:104253. doi: 10.1016/j.cellimm.2020.104253. Epub 2020 Dec 3.
Abstract
摘要
相似文献
1
Novel T regulatory cells come of age: The curious incident of a mouse in Tennessee, delayed thymectomy and chimeric receptors!新型调节性T细胞走向成熟：田纳西州一只小鼠的离奇事件、延迟胸腺切除术和嵌合受体！
Cell Immunol. 2021 Jan;359:104253. doi: 10.1016/j.cellimm.2020.104253. Epub 2020 Dec 3.
2
[Regulatory T cells in cancer immunotherapy].[癌症免疫疗法中的调节性T细胞]
Rinsho Ketsueki. 2014 Oct;55(10):2183-9.
3
Current trends with FOXP3 regulatory T cell immunotherapy to contest autoimmunity and inflammation.利用FOXP3调节性T细胞免疫疗法对抗自身免疫和炎症的当前趋势。
Immunotherapy. 2019 Jun;11(9):755-758. doi: 10.2217/imt-2019-0069. Epub 2019 May 16.
4
Infectious tolerance. What are we missing?感染性耐受。我们遗漏了什么？
Cell Immunol. 2020 Aug;354:104152. doi: 10.1016/j.cellimm.2020.104152. Epub 2020 Jun 12.
5
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.癌症中调节性T细胞的代谢调控：免疫治疗的机遇
Trends Cancer. 2017 Aug;3(8):583-592. doi: 10.1016/j.trecan.2017.06.005. Epub 2017 Jul 14.
6
Future prospects for CD8 regulatory T cells in immune tolerance.CD8 调节性 T 细胞在免疫耐受中的未来前景。
Immunol Rev. 2019 Nov;292(1):209-224. doi: 10.1111/imr.12812. Epub 2019 Oct 8.
7
Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?调控免疫细胞：引入抗原特异性调节 T 细胞治疗自身免疫疾病的下一步？
Cell Immunol. 2020 Dec;358:104236. doi: 10.1016/j.cellimm.2020.104236. Epub 2020 Oct 13.
8
Dichotomy between the induction of suppressor cells and immunologic tolerance by adult thymectomy.成年胸腺切除术后抑制性细胞诱导与免疫耐受之间的二分法。
J Exp Med. 1980 Mar 1;151(3):743-8. doi: 10.1084/jem.151.3.743.
9
Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.2008 - 2018年芬兰过敏计划的科学依据：强调预防与支持耐受
Allergy. 2009 May;64(5):678-701. doi: 10.1111/j.1398-9995.2009.02024.x.
10
Long-term prevention of chronic allograft rejection by regulatory T-cell immunotherapy involves host Foxp3-expressing T cells.调节性 T 细胞免疫疗法通过诱导供体来源的 Foxp3 表达 T 细胞来长期预防慢性移植物排斥反应。
Blood. 2013 May 23;121(21):4303-10. doi: 10.1182/blood-2012-08-452037. Epub 2013 Apr 11.
引用本文的文献
1
Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance.CAR-T 疗法：通往特定调节性 T 细胞耐受的曲折道路。
Front Immunol. 2021 Sep 6;12:742719. doi: 10.3389/fimmu.2021.742719. eCollection 2021.
本文引用的文献
1
Role of orally induced regulatory T cells in immunotherapy and tolerance.口服诱导的调节性 T 细胞在免疫治疗和耐受中的作用。
Cell Immunol. 2021 Jan;359:104251. doi: 10.1016/j.cellimm.2020.104251. Epub 2020 Nov 14.
2
Conventional T cell therapies pave the way for novel Treg therapeutics.常规 T 细胞疗法为新型 Treg 疗法铺平了道路。
Cell Immunol. 2021 Jan;359:104234. doi: 10.1016/j.cellimm.2020.104234. Epub 2020 Oct 12.
3
Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?调控免疫细胞：引入抗原特异性调节 T 细胞治疗自身免疫疾病的下一步？
Cell Immunol. 2020 Dec;358:104236. doi: 10.1016/j.cellimm.2020.104236. Epub 2020 Oct 13.
4
Building a CAR-Treg: Going from the basic to the luxury model.构建 CAR-Treg：从基础模型到豪华模型。
Cell Immunol. 2020 Dec;358:104220. doi: 10.1016/j.cellimm.2020.104220. Epub 2020 Sep 28.
5
Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor.针对 1 型糖尿病的抗原特异性 Tregs：基于胰腺内分泌标志物 HPi2 的嵌合抗原受体的构建和功能评估。
Cell Immunol. 2020 Dec;358:104224. doi: 10.1016/j.cellimm.2020.104224. Epub 2020 Sep 30.
6
Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.表达髓鞘特异性嵌合抗原受体的工程化调节性 T 细胞可抑制 EAE 的进展。
Cell Immunol. 2020 Dec;358:104222. doi: 10.1016/j.cellimm.2020.104222. Epub 2020 Oct 1.
7
CD4 T cells engineered with FVIII-CAR and murine Foxp3 suppress anti-factor VIII immune responses in hemophilia a mice.经 FVIII-CAR 和鼠 Foxp3 工程化的 CD4 T 细胞可抑制血友病 A 小鼠的抗 FVIII 免疫反应。
Cell Immunol. 2020 Dec;358:104216. doi: 10.1016/j.cellimm.2020.104216. Epub 2020 Sep 16.
8
CD8+ T cells: The past and future of immune regulation.CD8+ T 细胞：免疫调节的过去与未来。
Cell Immunol. 2020 Nov;357:104212. doi: 10.1016/j.cellimm.2020.104212. Epub 2020 Sep 4.
9
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use.鉴定、选择和扩增非基因修饰的同种抗原反应性 Tregs 用于临床治疗用途。
Cell Immunol. 2020 Nov;357:104214. doi: 10.1016/j.cellimm.2020.104214. Epub 2020 Sep 9.
10
The hepatic microenvironment and regulatory T cells.肝脏微环境与调节性 T 细胞。
Cell Immunol. 2020 Nov;357:104195. doi: 10.1016/j.cellimm.2020.104195. Epub 2020 Aug 14.
Zotero 插件